In this episode of Morning Commute, Dr. Charles Vega and Dr. Soo Borson tackle the challenging topics of how clinicians differentiate between normal aging and cognitive decline, and what screening tools and diagnostic strategies help arrive at a diagnosis of Alzheimer’s disease.

Visit podcasts.atpointofcare.com to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

This podcast is powered by Pinecast.

In this episode, Brain Health From Aging to Alzheimer’s Disease – Starting the Conversation, Dr. Charles Vega and Dr. Anna Chodos discuss the often difficult aspects of broaching conversations with patients about brain health and cognitive concerns. To better elucidate how clinicians can best help their patients, Debbie Casuto, a caregiver, joins them in this important discussion. Visit podcasts.atpointofcare.com to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

This podcast is powered by Pinecast.

In this episode, Getting a Grip on CIDP, Dr. Diana Castro and Dr. Jeffrey Allen discuss some of the latest presentations and clinical data coming out of the 2024 American Academy of Neurology meeting.

Visit https://suitehome.atpointofcare.com/library/2639.12/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

In this episode, A Deeper Look at CIDP Diagnosis and Treatment. Dr. Diana Castro and Dr. Jeffrey Allen discuss diagnosing CIPD with a focus on updates to the current guidelines for optimal treatment and management. Visit https://suitehome.atpointofcare.com/library/2639.11/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

In this episode our faculty take a look at the treatment-related side effects associated with some of the newer treatments for Alzheimer’s disease, with a focus on amyloid-related imaging abnormalities (ARIA). How do you weigh the risk and benefits for your patients?

Visit www.morningcommutepodcast.com/alzheimers3 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.

In this podcast, our faculty discuss talk some of the newer treatments for Alzheimer's disease, especially anti-beta-amyloid antibody treatments.

Visit www.morningcommutepodcast.com/alzheimers2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.

When is a patients cognitive difficulties a signal that they may be on the road to Alzheimer's disease? Our faculty discuss some of the recent advances making this diagnosis.

Visit www.morningcommutepodcast.com/alzheimers1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.

In this episode, our faculty looks at the latest treatments for multiple sclerosis—the newest sphingosine-1-phosphate receptor modulators. What is their mechanism of action? Which patients would benefit from them, and how are side effects and toxicities managed with these latest treatment options?

Visit www.morningcommutepodcast.com/ms8 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit